ProShare Advisors
BMRN icon

ProShare Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$861K Sell
15,666
-1,060
-6% -$58.3K ﹤0.01% 873
2025
Q1
$1.18M Sell
16,726
-1,218
-7% -$86.1K ﹤0.01% 773
2024
Q4
$1.18M Sell
17,944
-1,605
-8% -$105K ﹤0.01% 849
2024
Q3
$1.37M Sell
19,549
-1,128
-5% -$79.3K ﹤0.01% 728
2024
Q2
$1.7M Buy
20,677
+7,456
+56% +$614K ﹤0.01% 685
2024
Q1
$1.15M Buy
13,221
+1,185
+10% +$103K ﹤0.01% 760
2023
Q4
$1.16M Sell
12,036
-266
-2% -$25.6K ﹤0.01% 731
2023
Q3
$1.09M Buy
12,302
+157
+1% +$13.9K ﹤0.01% 718
2023
Q2
$1.05M Sell
12,145
-787
-6% -$68.2K ﹤0.01% 718
2023
Q1
$1.26M Sell
12,932
-5,258
-29% -$511K ﹤0.01% 700
2022
Q4
$1.88M Sell
18,190
-366
-2% -$37.9K 0.01% 630
2022
Q3
$1.57M Buy
18,556
+1,119
+6% +$94.9K 0.01% 655
2022
Q2
$1.45M Sell
17,437
-5,807
-25% -$481K ﹤0.01% 699
2022
Q1
$1.79M Sell
23,244
-7,226
-24% -$557K ﹤0.01% 742
2021
Q4
$2.69M Sell
30,470
-13,044
-30% -$1.15M 0.01% 699
2021
Q3
$3.36M Buy
43,514
+4,065
+10% +$314K 0.01% 595
2021
Q2
$3.29M Buy
39,449
+10,866
+38% +$907K 0.01% 596
2021
Q1
$2.16M Sell
28,583
-2,700
-9% -$204K 0.01% 679
2020
Q4
$2.74M Sell
31,283
-127,661
-80% -$11.2M 0.01% 561
2020
Q3
$12.1M Buy
158,944
+23,073
+17% +$1.76M 0.06% 256
2020
Q2
$16.8M Buy
135,871
+19,113
+16% +$2.36M 0.09% 183
2020
Q1
$9.87M Sell
116,758
-45,177
-28% -$3.82M 0.07% 237
2019
Q4
$13.7M Buy
161,935
+3,786
+2% +$320K 0.06% 268
2019
Q3
$10.7M Buy
158,149
+1,089
+0.7% +$73.4K 0.06% 307
2019
Q2
$13.5M Sell
157,060
-19,852
-11% -$1.7M 0.08% 212
2019
Q1
$15.7M Buy
176,912
+2,142
+1% +$190K 0.09% 178
2018
Q4
$14.9M Buy
174,770
+17,544
+11% +$1.49M 0.1% 166
2018
Q3
$15.2M Sell
157,226
-7,827
-5% -$759K 0.1% 160
2018
Q2
$15.5M Sell
165,053
-17,577
-10% -$1.66M 0.1% 161
2018
Q1
$14.8M Buy
182,630
+7,010
+4% +$568K 0.1% 178
2017
Q4
$15.7M Buy
175,620
+16,812
+11% +$1.5M 0.11% 160
2017
Q3
$14.8M Buy
158,808
+15,735
+11% +$1.46M 0.14% 143
2017
Q2
$13M Buy
143,073
+7,373
+5% +$670K 0.13% 145
2017
Q1
$11.9M Sell
135,700
-20,898
-13% -$1.83M 0.12% 145
2016
Q4
$13M Buy
156,598
+14,823
+10% +$1.23M 0.14% 129
2016
Q3
$13.1M Sell
141,775
-31,106
-18% -$2.88M 0.18% 105
2016
Q2
$13.5M Buy
172,881
+1,486
+0.9% +$116K 0.17% 117
2016
Q1
$14.1M Sell
171,395
-17,845
-9% -$1.47M 0.19% 116
2015
Q4
$19.8M Buy
189,240
+7,719
+4% +$809K 0.24% 115
2015
Q3
$19.1M Buy
181,521
+44,670
+33% +$4.7M 0.27% 90
2015
Q2
$18.7M Buy
136,851
+652
+0.5% +$89.2K 0.26% 90
2015
Q1
$17M Buy
136,199
+30,596
+29% +$3.81M 0.2% 115
2014
Q4
$9.55M Buy
105,603
+24,256
+30% +$2.19M 0.11% 203
2014
Q3
$5.87M Sell
81,347
-13,730
-14% -$991K 0.08% 245
2014
Q2
$5.92M Sell
95,077
-20,689
-18% -$1.29M 0.08% 245
2014
Q1
$7.9M Buy
115,766
+48,509
+72% +$3.31M 0.1% 173
2013
Q4
$4.73M Buy
67,257
+13,951
+26% +$980K 0.07% 322
2013
Q3
$3.85M Buy
53,306
+22,985
+76% +$1.66M 0.09% 173
2013
Q2
$1.69M Buy
+30,321
New +$1.69M 0.03% 542